GW Pharmaceuticals PLC EPS - Earnings per Share 2016-2021 | GWPH
GW Pharmaceuticals PLC eps - earnings per share from 2016 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| GW Pharmaceuticals PLC Annual EPS |
| 2020 |
$-1.86 |
| 2019 |
$-0.29 |
| 2018 |
$0.00 |
| 2018 |
$-10.56 |
| 2017 |
$-6.72 |
| 2016 |
$-4.02 |
| 2015 |
$-3.33 |
| 2014 |
$0.00 |
| 2012 |
$0.00 |
| GW Pharmaceuticals PLC Quarterly EPS |
| 2021-03-31 |
$-0.62 |
| 2020-12-31 |
$-1.00 |
| 2020-09-30 |
$-0.36 |
| 2020-06-30 |
$-0.24 |
| 2020-03-31 |
$-0.26 |
| 2019-12-31 |
$-0.65 |
| 2019-09-30 |
$-0.48 |
| 2019-06-30 |
$2.52 |
| 2019-03-31 |
$-1.68 |
| 2018-12-31 |
$0.00 |
| 2018-09-30 |
$-2.76 |
| 2018-06-30 |
$-3.00 |
| 2018-03-31 |
$-2.40 |
| 2017-12-31 |
$-2.44 |
| 2017-06-30 |
$-2.08 |
| 2017-03-31 |
$-1.70 |
| 2016-12-31 |
$-0.77 |
| 2016-06-30 |
$-0.73 |
| 2016-03-31 |
$-1.10 |
| 2015-12-31 |
$-1.24 |
